{"id":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","kind":"companies","code":"UB-C7640","name":"Superluminal Medicines","nameBasis":"source-english","summary":"Superluminal Medicines is a company headquartered in United States.","description":"","country":"United States","category":null,"originalName":"Superluminal Medicines","eventDate":null,"website":"https://www.superluminalrx.com/","sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-16T01:39:37.479Z","reviewedAt":"2026-10-16T01:39:37.479Z","snapshotAt":"2026-10-16T01:37:30.476Z","sourceHash":"474e300951aa7870f062ba3b20ac3c2c5752f48a19f668fad295bd5d0edc3d32","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":null,"category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.049Z","englishUpdatedAt":"2026-10-16T01:39:37.744Z","reviewedAt":"2026-10-16T01:39:37.744Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"29917d95c3147db429ab2cdc84b1e70e989666b45ca6f7d0da42946f5c20d24f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":null,"category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.111Z","englishUpdatedAt":"2026-10-16T01:39:37.635Z","reviewedAt":"2026-10-16T01:39:37.635Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"105ee39856c232d2c629cefd964939faec8c928054bdf7b307b5018c9b26d2f2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":null,"category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.106Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d6566087b9fdc5b8f4f0465bf7ab3f9f72a59bd6a72e5909ae3d2badb51d2379","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"news","code":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","name":"Superluminal Medicines raises USD 120 million in Series A financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成1.2亿美元A轮融资","eventDate":"2024-09-09T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T09:54:27.118Z","englishUpdatedAt":"2026-10-15T17:19:59.178Z","reviewedAt":"2026-10-15T17:19:59.178Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"dad4fa4c64ac255cdb6fbb7b3cdf1ed0bfd304e3c8f6cb55d15dd5d95c6b3db7","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef"},{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"news","code":"22da73b7-c7eb-4a01-b246-146e4f248acc","name":"Superluminal Medicines raises USD 60 million in Series B financing","nameBasis":"translated-title","summary":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","description":"","country":null,"category":null,"originalName":"Superluminal Medicines完成B轮融资，融资金额6000万美元","eventDate":"2026-09-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:42:26.621Z","englishUpdatedAt":"2026-10-15T20:50:21.999Z","reviewedAt":"2026-10-15T20:50:21.999Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e8e7b1b012c19476316906130fd4ae28ebac9db6102a8c78bc6bf24e9a1a83b0","companyId":"7c66c728-c0c9-4716-992b-f0a5fc8d890e","foundedYear":null,"logoUrl":null,"path":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc"}],"finance":{"funding":{"metric":"funding","count":2,"latest":{"value":60000000,"text":"6000万美元","date":"2026-09-03T00:00:00.000Z","round":"Series B","estimate":"$60M"},"years":[2024,2026],"points":[{"year":2024,"date":"2024-09-09T00:00:00.000Z","round":"Series A","value":120000000,"eventIds":["012b0b52-17af-4d30-9e8c-80a80b69a5ef"]},{"year":2026,"date":"2026-09-03T00:00:00.000Z","round":"Series B","value":60000000,"eventIds":["22da73b7-c7eb-4a01-b246-146e4f248acc"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","date":"2026-09-03T00:00:00.000Z","round":"Series B","amountText":"6000万美元","estimateUsd":60000000,"estimateLabel":"$60M","estimateNote":null,"investors":"BVF Partners领投，RA Capital Management、Perceptive Advisors、NVIDIA、Insight Partners、Gaingels、Eli Lilly、Deep Track Capital、Cooley、Catalio Capital Management跟投","institutions":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":null,"category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.049Z","englishUpdatedAt":"2026-10-16T01:39:37.744Z","reviewedAt":"2026-10-16T01:39:37.744Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"29917d95c3147db429ab2cdc84b1e70e989666b45ca6f7d0da42946f5c20d24f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":null,"category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.111Z","englishUpdatedAt":"2026-10-16T01:39:37.635Z","reviewedAt":"2026-10-16T01:39:37.635Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"105ee39856c232d2c629cefd964939faec8c928054bdf7b307b5018c9b26d2f2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":null,"category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.106Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d6566087b9fdc5b8f4f0465bf7ab3f9f72a59bd6a72e5909ae3d2badb51d2379","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"newsUrl":null,"evidence":{"headline":"Superluminal Medicines raises USD 60 million in Series B financing","brief":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","basis":"translated-source-brief","newsPath":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc","sourceCount":0}},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","date":"2024-09-09T00:00:00.000Z","round":"Series A","amountText":"1.2亿美元","estimateUsd":120000000,"estimateLabel":"$120M","estimateNote":null,"investors":"RA Capital Management,Insight Partners,NVentures(NVDA),Gaingels,Catalio Capital Management,Eli Lilly,科律律师事务所","institutions":[{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"newsUrl":null,"evidence":{"headline":"Superluminal Medicines raises USD 120 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":2,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":2,"records":[{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","date":"2026-09-03T00:00:00.000Z","round":"Series B","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"BVF Partners领投，RA Capital Management、Perceptive Advisors、NVIDIA、Insight Partners、Gaingels、Eli Lilly、Deep Track Capital、Cooley、Catalio Capital Management跟投","institutions":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":null,"category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.049Z","englishUpdatedAt":"2026-10-16T01:39:37.744Z","reviewedAt":"2026-10-16T01:39:37.744Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"29917d95c3147db429ab2cdc84b1e70e989666b45ca6f7d0da42946f5c20d24f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":null,"category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.111Z","englishUpdatedAt":"2026-10-16T01:39:37.635Z","reviewedAt":"2026-10-16T01:39:37.635Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"105ee39856c232d2c629cefd964939faec8c928054bdf7b307b5018c9b26d2f2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":null,"category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.106Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d6566087b9fdc5b8f4f0465bf7ab3f9f72a59bd6a72e5909ae3d2badb51d2379","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"newsUrl":null,"evidence":{"headline":"Superluminal Medicines raises USD 60 million in Series B financing","brief":"On 2026-09-03, according to Xiniu Data, Superluminal Medicines completed Series B financing, raising USD 60 million. Investors were lead investor BVF Partners, RA Capital Management, Perceptive Advisors, NVIDIA and others. The company is a provider of U.S. AI generation drugs services.","basis":"translated-source-brief","newsPath":"/news/22da73b7-c7eb-4a01-b246-146e4f248acc","sourceCount":0}},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","date":"2024-09-09T00:00:00.000Z","round":"Series A","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"RA Capital Management,Insight Partners,NVentures(NVDA),Gaingels,Catalio Capital Management,Eli Lilly,科律律师事务所","institutions":[{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"newsUrl":null,"evidence":{"headline":"Superluminal Medicines raises USD 120 million in Series A financing","brief":null,"basis":null,"newsPath":"/news/012b0b52-17af-4d30-9e8c-80a80b69a5ef","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"22da73b7-c7eb-4a01-b246-146e4f248acc","kind":"funding","eventDate":"2026-09-03T00:00:00.000Z","revenueDate":null,"round":"B轮","amountText":"6000万美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":60000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"BVF Partners领投，RA Capital Management、Perceptive Advisors、NVIDIA、Insight Partners、Gaingels、Eli Lilly、Deep Track Capital、Cooley、Catalio Capital Management跟投","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":null,"category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.049Z","englishUpdatedAt":"2026-10-16T01:39:37.744Z","reviewedAt":"2026-10-16T01:39:37.744Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"29917d95c3147db429ab2cdc84b1e70e989666b45ca6f7d0da42946f5c20d24f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":null,"category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.111Z","englishUpdatedAt":"2026-10-16T01:39:37.635Z","reviewedAt":"2026-10-16T01:39:37.635Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"105ee39856c232d2c629cefd964939faec8c928054bdf7b307b5018c9b26d2f2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":null,"category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.106Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d6566087b9fdc5b8f4f0465bf7ab3f9f72a59bd6a72e5909ae3d2badb51d2379","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"roundName":"Series B","amountLabel":"$60M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"012b0b52-17af-4d30-9e8c-80a80b69a5ef","kind":"funding","eventDate":"2024-09-09T00:00:00.000Z","revenueDate":null,"round":"A轮","amountText":"1.2亿美元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":120000000,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"RA Capital Management,Insight Partners,NVentures(NVDA),Gaingels,Catalio Capital Management,Eli Lilly,科律律师事务所","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"roundName":"Series A","amountLabel":"$120M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"5f0994d5-b33f-471e-8472-472a85be2a69","kind":"institutions","code":"UB-I7475","name":"BVF Partners","nameBasis":"original-brand","summary":"BVF Partners, a growth equity investment firm.","description":"BVF Partners, a growth equity investment firm.","country":null,"category":null,"originalName":"BVF Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.049Z","englishUpdatedAt":"2026-10-16T01:39:37.744Z","reviewedAt":"2026-10-16T01:39:37.744Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"29917d95c3147db429ab2cdc84b1e70e989666b45ca6f7d0da42946f5c20d24f","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/bvf-partners"},{"id":"95d6af86-e104-4512-be32-a32ef1a9ac68","kind":"institutions","code":"UB-I145","name":"Catalio Capital Management","nameBasis":"original-brand","summary":"An investment firm focused on life sciences and healthcare.","description":"An investment firm focused on life sciences and healthcare.","country":null,"category":null,"originalName":"Catalio Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:56:17.814Z","englishUpdatedAt":"2026-10-15T20:40:58.165Z","reviewedAt":"2026-10-15T20:40:58.165Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3681c48034ed8b622dceabf6c91f2d394b390b9f30292e4a1f99e80c60a8a4bb","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/catalio-capital-management"},{"id":"479a9c91-684c-48df-b111-80fcf5f8783a","kind":"institutions","code":"UB-I541","name":"Cooley","nameBasis":"original-brand","summary":"Investment affiliated with Cooley law firm.","description":"Investment affiliated with Cooley law firm.","country":null,"category":null,"originalName":"Cooley","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T10:46:24.028Z","englishUpdatedAt":"2026-10-15T20:13:55.852Z","reviewedAt":"2026-10-15T20:13:55.852Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"772229fe471c72f1f340b75bffafcb026b460730e3de5107226ac2b557a6b49b","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/cooley"},{"id":"14a06fcf-b5ca-49e4-9788-429c0331d5c9","kind":"institutions","code":"UB-I7418","name":"Deep Track Capital","nameBasis":"original-brand","summary":"Deep Track Capital is a U.S. early-stage venture capital firm.","description":"Deep Track Capital is a U.S. early-stage venture capital firm.","country":null,"category":null,"originalName":"Deep Track Capital","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.111Z","englishUpdatedAt":"2026-10-16T01:39:37.635Z","reviewedAt":"2026-10-16T01:39:37.635Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"105ee39856c232d2c629cefd964939faec8c928054bdf7b307b5018c9b26d2f2","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/deep-track-capital"},{"id":"c4d6bbd2-be93-4c8c-b3f8-670870244af3","kind":"institutions","code":"UB-I5537","name":"Eli Lilly","nameBasis":"original-brand","summary":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","description":"Eli Lilly is a U.S. corporate investment platform making strategic investments in growth-stage and mature companies.","country":null,"category":null,"originalName":"Eli Lilly","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:06:27.642Z","englishUpdatedAt":"2026-10-15T17:35:39.708Z","reviewedAt":"2026-10-15T17:35:39.708Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"be93211139cb262dbad90ea7ccc8c5ac919d18487ec4a37a8730a93ad0d87add","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly"},{"id":"889bf577-45e9-4bcf-8a86-448147e2d494","kind":"institutions","code":"UB-I926","name":"Eli Lilly and Company","nameBasis":"original-brand","summary":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","description":"Strategic investment division of multinational pharmaceutical company Eli Lilly.","country":null,"category":null,"originalName":"Eli Lilly and Company","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:19.540Z","englishUpdatedAt":"2026-10-15T20:18:30.627Z","reviewedAt":"2026-10-15T20:18:30.627Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c411259d2de066409798e6f87bf1d3b438ae59378de955dfc1da3a5f335c73c9","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/eli-lilly-and-company"},{"id":"3409c90e-a603-48b3-b175-6b6608175f4e","kind":"institutions","code":"UB-I838","name":"Gaingels","nameBasis":"original-brand","summary":"A well-known US angel co-investment syndicate network.","description":"A well-known US angel co-investment syndicate network.","country":null,"category":null,"originalName":"Gaingels","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:30.011Z","englishUpdatedAt":"2026-10-15T21:02:48.735Z","reviewedAt":"2026-10-15T21:02:48.735Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e414fb5d0309c7ea8cc69b8ec7ac0149096a186a3ed83242bca8fb660d4791fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/gaingels"},{"id":"10eab593-16d3-4f37-ae9c-64d51d8a9475","kind":"institutions","code":"UB-I043","name":"Insight Partners","nameBasis":"original-brand","summary":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","description":"A globally prominent growth-stage venture capital firm in software and SaaS, focused on high-growth technology enterprises.","country":null,"category":null,"originalName":"Insight Partners","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.736Z","englishUpdatedAt":"2026-10-15T21:38:48.439Z","reviewedAt":"2026-10-15T21:38:48.439Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f4565a4fbf5ccce8d45edcc38b4e9ca6483d45a13dafad48a0f5844df2121da1","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/insight-partners"},{"id":"bb3a0968-c147-4064-86ac-f87a6b2c3336","kind":"institutions","code":"UB-I084","name":"NVIDIA","nameBasis":"original-brand","summary":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","description":"NVIDIA's strategic investment division, focused on enterprises in AI, GPU computing, and related ecosystems.","country":null,"category":null,"originalName":"NVIDIA","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T11:22:28.514Z","englishUpdatedAt":"2026-10-15T21:37:02.777Z","reviewedAt":"2026-10-15T21:37:02.777Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8a62c3d17681228b0f2100d52b9d441c8cbf7cd76ff11e3f9d0dc9bf9d6cb200","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/nvidia"},{"id":"214cbe99-b127-4a38-8e04-68dbf2b156eb","kind":"institutions","code":"UB-I7521","name":"Perceptive Advisors","nameBasis":"original-brand","summary":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","description":"Perceptive Advisors, a US healthcare hedge fund and growth investment firm.","country":null,"category":null,"originalName":"Perceptive Advisors","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:14.106Z","englishUpdatedAt":"2026-10-16T01:39:37.652Z","reviewedAt":"2026-10-16T01:39:37.652Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"d6566087b9fdc5b8f4f0465bf7ab3f9f72a59bd6a72e5909ae3d2badb51d2379","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/perceptive-advisors"},{"id":"84cacc56-8b65-4ff8-a7ba-456e915dddae","kind":"institutions","code":"UB-I3822","name":"RA Capital Management","nameBasis":"original-brand","summary":"Investment firm focused on biotechnology and healthcare.","description":"Investment firm focused on biotechnology and healthcare.","country":null,"category":null,"originalName":"RA Capital Management","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T17:04:13.435Z","englishUpdatedAt":"2026-10-15T18:45:27.783Z","reviewedAt":"2026-10-15T18:45:27.783Z","snapshotAt":"2026-10-15T18:31:23.182Z","sourceHash":"9efdf935b1711e3645661d73e90bdd347cea2120ff6751766a951bcbbdce77ec","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ra-capital-management"}],"path":"/companies/superluminal-medicines","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Superluminal Medicines is a company headquartered in United States.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/companies/superluminal-medicines"}